CASE REPORT
Neck phlegmon in COVID-19 patients
1
Department of Otorhinolaryngology, Provincial Polyclinic Hospital, Kielce, Poland
2
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Submission date: 2021-06-01
Final revision date: 2021-08-28
Acceptance date: 2021-09-03
Publication date: 2021-12-31
Medical Studies 2021;37(4):349-353
KEYWORDS
TOPICS
ABSTRACT
Reports on patients hospitalised due to inflammatory diseases of the soft tissues in the head suggest worsening of the course of the underlying disease in the case of coexisting infection with the SARS-CoV-2 virus. The cases of 2 patients with neck phlegmon in the course of Coronavirus disease 19 (COVID-19) hospitalised at our Otorhinolaryngological Unit have been presented in the paper. Despite intensive treatment, the disease was fatal in both cases. COVID-19 probably has a significant impact on the course of disease and treatment results in the cases of patients with neck phlegmon. Coexisting diseases may seriously worsen the prognosis in patients with neck phlegmon and COVID-19. Further research is required to explain the mechanism of the impact of SARS-CoV-2 infection on the course of phlegmon in the head and neck region.
REFERENCES (31)
1.
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8: 475-481.
2.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
3.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062.
4.
Markowski J, Dziubdziela W, Wardas P, Piotrowska A, Sowinska-Krzyzanowska I, Gierek T, Paluch J, Konopka A. Head and neck phlegmons – diagnosis and treatment – own observations. Otolaryngol Pol 2012; 66: 207-213.
5.
Tran Ba Huy P, Blancal JP, Verillaud B, Mebazaa A, Herman P. Cervico-facial fascitiis. A major ENT emergency. Bull Acad Natl Med 2011; 195: 661-676.
6.
Turbin RE, Wawrzusin PJ, Sakla NM, Traba CM, Wong KG, Mirani N, Eloy JA, Nimchinsky EA. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19. Orbit 2020; 39: 305-310.
7.
Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Yamin M, Nasution SA, Setiati S, Virani SS. Elevated interleukin levels are associated with higher severity and mortality in COVID 19 – a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2020; 14: 2219-2230.
8.
Talamonti G, Colistra D, Crisa F, Cenzato M, Giorgi P, D’Aliberti G. Spinal epidural abscess in COVID-19 patients. J Neurol 2020. doi: 10.1007/s00415-020-10211-z.
9.
Ajeigbe T, Ria B, Wates E, Mattine S. Severe parapharyngeal abscess that developed significant complications: management during the COVID-19 pandemic. BMJ Case Rep 2020; 13: e236449.
10.
Maan AS, Kaur G, Arora R, Kaur J, Devi KJ, Singh M. An unusual case of a pediatric nasal septal abscess with life-threatening complications in COVID-19 pandemic. Indian J Otolaryngol Head Neck Surg 2020. doi: 10.1007/s12070-020-02264-3.
11.
Tadic M, Cuspidi C, Sala C. COVID-19 and diabetes: is there enough evidence? J Clin Hypertens 2020; 22: 943-948.
12.
Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 2020; 14: 303-310.
13.
Abdi A, Jalilian M, Sarbarzeh PA, Vlaisavljevic Z. Diabetes and COVID-19: a systematic review on the current evidences. Diabetes Res Clin Pract 2020; 166: 108347.
14.
Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr 2020; 14: 535-545.
15.
Pal R, Bhadada SK. COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes Metab Syndr 2020; 14: 513-517.
16.
Peterson E, Lo KB, DeJoy R, Salacup G, Pelayo J, Bhargav R, Gul F, Albano J, Azmaiparashvili Z, Amanullah A, Patarroyo-Aponte G. The relationship between coronary artery disease and clinical outcomes in COVID-19: a single-center retrospective analysis. Coron Artery Dis 2021; 32: 367-371.
17.
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 2020; 382: e102.
18.
Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore D, Curnis A, Faggiano P, Gorga E, Lombardi CM, Milesi G, Vizzardi E, Volpini M, Nodari S, Specchia C, Maroldi R, Bezzi M, Metra M. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 2020; 41: 1821-1829.
19.
Liu H, Chen S, Liu M, Nie H, Lu H. Comorbid chronic diseases are strongly correlated with disease severity among covid-19 patients: a systematic review and meta-analysis. Aging Dis 2020; 11: 668-678.
20.
Xie Y, You Q, Wu C, Cao S, Qu G, Yan X, Han X, Wang C, Zhang H. Impact of cardiovascular disease on clinical characteristics and outcomes of coronavirus disease 2019 (COVID-19). Circ J 2020; 84: 1277-1283.
21.
De Cauwer H, Spaepen A. Are patients with Down syndrome vulnerable to life-threatening COVID-19? Acta Neurol Belg 2021; 121: 685-687.
22.
Bertapelli F, Pitetti K, Agiovlasitis S, Guerra-Junior G. Overweight and obesity in children and adolescents with Down syndrome-prevalence, determinants, consequences, and interventions: a literature review. Res Dev Disabil 2016; 57: 181-192.
23.
Espinosa JM. Down syndrome and COVID-19: a perfect storm? Cell Rep Med 2020; 1: 100019.
24.
Callea M, Cammarata-Scalisi F, Galeotti A, Villani A, Valentini D. COVID-19 and Down syndrome. Acta Paediatr 2020; 109: 1901-1902.
25.
Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis 2020; 20: 773.
26.
Dard R, Janel N, Vialard F. COVID-19 and Down’s syndrome: are we heading for a disaster? Eur J Hum Genet 2020; 28: 1477-1478.
27.
Malle L, Gao C, Hur C, Truong HQ, Bouvier NM, Percha B, Kong XF, Bogunovic D. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease. Genet Med 2021; 23: 576-580.
28.
Huls A, Costa ACS, Dierssen M, Baksh RA, Bargagna S, Baumer NT, Brandão AC, Carfi A, Carmona-Iragui M, Chicoine BA, Ghosh S, Lakhanpaul M, Manso C, Mayer MA, del Carmen Ortega M, Real de Asua D, Rebil lat AS, Russell LA, Sgandurra G, Valentini D, Sherman SL, Strydom A. An international survey on the impact of spacje COVID-19 in individuals with Down syndrome. medRxiv 2020. doi: 10.1101/2020.11.03.20225359.
29.
Cammarata-Scalisi F, Cardenas Tadich A, Medina M, Callea M. Trisomy 21 and the coronavirus disease 2019 (COVID-19). Arch Argent Pediatr 2020; 118: 230-231.
30.
Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: a systematic review. Diabetes Metab Syndr 2020; 14: 655-659.
31.
Zhang F, Xiong Y, Wei Y, Hu Y, Wang F, Li G, Liu K, Du R, Wang CY, Zhu W. Obesity predisposes to the risk of higher mortality in young COVID-19 patients. J Med Virol 2020; 92: 2536-2542.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
